Endolysosomal Dysfunction

Endolysosomal Dysfunction enters the Adult Cognitive Disease corpus through the submissions of Zhen Huang (submission 28) and Varghese John (submission 78), and is indexed here as one of the concepts that submission puts to work.

The argument it belongs to

Zhen Huang's submission is summarised in this corpus as:

The Axonal Competition Hypothesis proposes that amyloid-beta is an evolutionarily conserved signaling molecule mediating activity-dependent synaptic competition via concentration-dependent duality: protective monomers shield active synapses through PI3K/Akt signaling while toxic oligomers prune weaker competitors via PirB/NgR receptors. Pathological aggregation depletes the protective monomer pool, disinhibiting microglial TNF-alpha release which inhibits neuronal V-ATPase.

Where it sits

The submission scores against the framework's convergence nodes as: compensatory paradigm 9 · endosomal nexus 8 · cytoskeletal collapse 7 · neuroimmune interface 7 · ApoE4 hub 2.

Its declared subject matter: synaptic-competition, antimicrobial-peptide, quorum-sensing, neuroinflammation, microglial-regulation, endocytosis, monomer-oligomer-duality, evolutionary-biology, TNF-alpha, V-ATPase.

The argument it belongs to

Varghese John's submission is summarised in this corpus as:

Apolipoprotein E4 (ApoE4), the major genetic risk factor for sporadic late-onset Alzheimer's disease, exerts a broad panoply of pro-AD effects rather than acting through a single pathway. ApoE4 shifts APP processing toward amyloidogenic cleavage (raising BACE1, lowering ADAM10/sAPPalpha), represses the longevity deacetylase Sirtuin 1 (SirT1), and drives mitochondrial dysfunction, lysosomal leakage, and tau phosphorylation. The proposal applies a systems-pharmacology drug-discovery approach to develop first-in-class, brain-permeable small molecules that target these ApoE4 mechanisms for multi-modal AD therapy.

Where it sits

The submission scores against the framework's convergence nodes as: endosomal nexus 9 · ApoE4 hub 9 · transcriptional / epigenetic 8 · cytoskeletal collapse 2 · compensatory paradigm 2 · neuroimmune interface 1.

Its declared subject matter: apoe4, systems-pharmacology, sirtuin-1, app-processing, bace1, adam10, lysosomal-dysfunction, multi-modal-therapy.

Use in the corpus

Referred to by 4 documents in the research corpus, including research/ramsden-lipid-peroxidation/The_Bond_Not_Made.md, research/small-endosomal-recycling/Causal_and_Common.md, research/synaptic-integration/The_Return_Leg.md, research/synaptic-integration/src/07_partV.md.

Named by the same submission

12 other concepts enter the corpus through the same paper, so they cover adjacent ground: Innate Immunity · Microglial Immunometabolism · Neuroinflammation · Synaptic Competition · Synaptic Pathology · Autophagy · Epigenetic Repression · Selective Tau Disruption · Systems Biology · Tau Propagation · Tau Scaffolding Interactions · Vesicular Trafficking.

Assembled from the corpus rather than written: the summary is quoted from the submission that named it; the node scores are read from its dossier; the reference count is measured across the research corpus. It has not yet been expanded into an article.